Sage Journals: Discover world-class research

Abstract

Italian

Innovative therapeutic applications that could lead to a new and different approach for the treatment of Addison's disease are considered and evaluated in this editorial. Even though the information on Addison's disease is still limited, mostly due to its rarity, the main pathogenetic mechanisms of the disease are here discussed as to explore potential future strategies for the treatment of this pathology. This editorial analyzes the genetic and immunological factors in Addison's disease, and tries to understand which could be the role of the adrenocortical stem cells for the regeneration of the glandular functions. At the end, after two clinical trials are pointed out, the editorial puts forward the hypothesis of some therapeutic possibilities that could open new perspectives on how to treat patients affected by this autoimmune disease.

Keywords

Addison's disease Cellular therapies Stem cells New therapeutic possibilities Morbo di Addison Terapie cellulari Cellule staminali Nuove possibilità terapeutiche

Get full access to this article

View all access options for this article.

References

Mitchell

A.L.

, Pearce

S.H.

. Autoimmune Addison disease: pathophysiology and genetic complexity. Nat Rev Endocrinol 2012; 8(5): 306–16.

Winqvist

, Karlsson

F.A.

, Kämpe

. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992; 339(8809): 1559–62.

Brozzetti

, Marzotti

, La Torre

. Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response. Eur J Endocrinol 2010; 163(2): 309–17.

Betterle

, Scalici

, Presotto

. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988; 117(3): 467–75.

Metzger

T.C.

, Anderson

M.S.

. Control of central and peripheral tolerance by Aire. Immunol Rev 2011; 241(1): 89–103.

Betterle

, Volpato

, Greggio

A.N.

, Presotto

. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab 1996; 9(Suppl 1); 113–23.

Chase

, Sargan

, Miller

, Ostrander

E.A.

, Lark

K.G.

. Understanding the genetics of autoimmune disease: two loci that regulate late onset Addison's disease in Portuguese Water Dogs. Int J Immunogenet 2006; 33(3): 179–84.

Brunet

J.F.

, Denizot

, Luciani

M.F.

. A new member of the immunoglobulin superfamily–CTLA-4. Nature 1987; 328(6127): 267–70.

Luo

, Ikeda

, Parker

K.L.

. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994; 77: 481–90.

10.

Ching

, Vilain

. Targeted disruption of sonic hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis 2009; 47: 628–37.

11.

Bartholomew

, Sturgeon

, Siatskas

. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30(1): 42–8.

12.

Krampera

, Cosmi

, Angeli

. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006; 24(2): 386–98.

13.

Cosmi

, Liotta

, Lazzeri

. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003; 102(12): 4107–14.

14.

Maggi

, Santarlasci

, Liotta

. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals. J Allergy Clin Immunol 2007; 120(2): 429–36.

Therapeutic Perspectives in the Treatment of Addison's Disease

Abstract

Keywords

Get full access to this article

References